Author/Authors :
Daar, Shahina Sultan Qaboos University - College of Medicine Health Sciences - Department of Haematology, Oman , Hassan, Moez Sultan Qaboos University Hospital - Departments of Haematology, Oman , Panjwani, Vinodh Sultan Qaboos University Hospital - Departments of Haematology, Oman , Pathare, Anil Sultan Qaboos University Hospital - Department of Haematology, Oman , Al-Dhuhli, Humoud Sultan Qaboos University Hospital - Department of Radiology and Molecular Imaging, Oman , Al-Riyami, Arwa Z. Sultan Qaboos University Hospital - Department of Haematology, Oman
Abstract :
Patients with beta thalassaemia major (TM) require regular blood transfusions in order to survive; however, these transfusions are associated with a risk of iron overload. Toxic levels of iron accumulate mainly in the liver, heart and endocrine organs, causing multiple complications, and can only be removed by the regular use of iron chelating agents.
